Clinical Trial Update: Investigation of 9 Consecutive Remicade Infusions in Ankylosing Spondylitis in Austria (Study P04044)(COMPLETED)

View source ↗

Summary

The study P04044 investigating nine consecutive Remicade infusions for ankylosing spondylitis in Austria has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Spondylitis, Ankylosing | Status: COMPLETED | Results posted: 2011-07-07